| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |